Behavioural Intervention
Sulforaphane for Autism
This trial tests if sulforaphane, a compound from broccoli, can improve symptoms in males with autism. Sulforaphane boosts protective enzymes and helps manage stress and immune responses. The study aims to see improvements in social interaction, behavior, and communication. Sulforaphane, derived from broccoli sprouts, has shown potential benefits in previous trials for improving behavior and social responsiveness in individuals with autism spectrum disorder (ASD).
Corticosteroid
Pregnenolone for Autism
This trial is testing pregnenolone, a natural hormone in the brain, to see if it can help people with autism. Pregnenolone is part of a neurosteroid pathway that has been studied for its potential therapeutic value in stress and drug abuse-related disorders. The goal is to find out if it can reduce irritability and sensitivity to sensory differences, and improve social communication. Researchers hope this will lead to better treatments for autism.
Behavioural Intervention
Training Programs for Autism
This trial is testing whether a training program called TEAMS, which uses Motivational Interviewing strategies, can help providers implement evidence-based interventions for children with autism spectrum disorder more effectively.
Dopamine Precursor
L-DOPA + Social Skills Training for Autism Spectrum Disorder
This trial will use L-DOPA or placebo to study social reward processes in adolescents and young adults with ASD, and how dopamine affects these processes. It will enroll 56 participants with ASD and 18 healthy controls.
Cognitive Remediation
Cognitive Enhancement Therapy for Autism
This trial will test two therapies for adults with autism. One therapy aims to improve thinking and planning through mental exercises. The other provides support to help manage emotions and social skills. The study focuses on adults because there are few treatments available for them.
Popular Filters
Trials for Asperger Syndrome Patients
Behavioural Intervention
Parent-Mediated Intervention for Autism Spectrum Disorder
This trial tests two therapies for young children with autism who haven't responded well to usual treatments. The therapies involve parents playing with their children to encourage communication and social skills. One therapy focuses on general improvement, while the other targets specific weaknesses.
Cannabinoid
CBD for Autism
This trial is testing if cannabidiol (CBD) can help with anxiety, mood issues, sleep problems, and agitation in adults with autism spectrum disorder (ASD). Participants will take CBD pills for a period of time. The study aims to see if CBD is effective and safe for these psychiatric problems. Cannabidiol (CBD) has shown promise in treating psychotic symptoms and anxiety, but there is not enough high-quality evidence for its clinical use in psychiatric disorders.
Atypical Antipsychotic
Risperidone vs Aripiprazole for Weight Gain in Children with Autism
This trial is comparing two medicines, aripiprazole and risperidone, to see which one causes more weight gain in children with autism. The study focuses on children under 18 who have behavior problems like irritability and aggression. These medicines help by calming brain activity to improve behavior. The main goal is to find out which medicine leads to less weight gain over a few months. Aripiprazole and risperidone are both FDA-approved for treating irritability in children with autism.
Behavioural Intervention
N-Acetylcysteine for Autism
This trial aims to see if NAC, a safe nutritional supplement, can help reduce repetitive behaviors in children with autism by balancing brain chemicals. N-Acetylcysteine (NAC) has been studied for its potential benefits in treating obsessive-compulsive spectrum disorders and irritability in autism spectrum disorders.
Trials for Autism Patients
Cannabinoid
CBD for Autism
This trial is testing if cannabidiol (CBD) can help with anxiety, mood issues, sleep problems, and agitation in adults with autism spectrum disorder (ASD). Participants will take CBD pills for a period of time. The study aims to see if CBD is effective and safe for these psychiatric problems. Cannabidiol (CBD) has shown promise in treating psychotic symptoms and anxiety, but there is not enough high-quality evidence for its clinical use in psychiatric disorders.
Atypical Antipsychotic
Risperidone vs Aripiprazole for Weight Gain in Children with Autism
This trial is comparing two medicines, aripiprazole and risperidone, to see which one causes more weight gain in children with autism. The study focuses on children under 18 who have behavior problems like irritability and aggression. These medicines help by calming brain activity to improve behavior. The main goal is to find out which medicine leads to less weight gain over a few months. Aripiprazole and risperidone are both FDA-approved for treating irritability in children with autism.
Behavioural Intervention
N-Acetylcysteine for Autism
This trial aims to see if NAC, a safe nutritional supplement, can help reduce repetitive behaviors in children with autism by balancing brain chemicals. N-Acetylcysteine (NAC) has been studied for its potential benefits in treating obsessive-compulsive spectrum disorders and irritability in autism spectrum disorders.
Probiotic
Combination Probiotic for Autism
This trial is looking at the effects of a probiotic on children with autism spectrum disorders. The probiotic will be given at different doses over 56 days, and then there will be a 28 day observation period. The trial will assess safety and tolerability of the probiotic, as well as any effects on behaviors, GI symptoms, and relevant biomarkers.
Phase 3 Trials
Atypical Antipsychotic
Cariprazine for Pediatric Schizophrenia
This trial is testing the safety and effectiveness of cariprazine in children and teens with schizophrenia, bipolar I disorder, or autism. The goal is to see if the medication is safe and beneficial for use in these young patients.
Serotonin Receptor Antagonist
Pimavanserin for Autism Spectrum Disorder
This trial is testing pimavanserin, a medication that may help reduce irritability in children and teenagers with autism. The study focuses on kids aged 5 to 17 who have this symptom. Pimavanserin works by balancing brain chemicals to help them feel calmer. The goal is to see if the medication is safe and effective over time.
Melatonin Receptor Agonist
Tasimelteon for Autism and Sleep Disorders
This trial is testing a daily pill called tasimelteon to help children and adults with Autism Spectrum Disorder (ASD) who have trouble sleeping. The medication aims to improve sleep by helping to regulate the body's internal clock.
Behavioral Intervention
Telehealth vs In-Person Behavior Therapy for Autism
This trial is aiming to find out if behavior therapy, which helps children with autism spectrum disorder (ASD) manage difficult behaviors, can be just as effective when done through telehealth (online) as
Antipsychotic
Lumateperone for Irritability in Autism
This trial will involve children between 5 and 17 years old with irritability associated with Autism Spectrum Disorder (ASD). The study will be conducted at multiple centers and will compare the effectiveness of a
Trials With No Placebo
Behavioural Intervention
Parent-Mediated Intervention for Autism Spectrum Disorder
This trial tests two therapies for young children with autism who haven't responded well to usual treatments. The therapies involve parents playing with their children to encourage communication and social skills. One therapy focuses on general improvement, while the other targets specific weaknesses.
Atypical Antipsychotic
Risperidone vs Aripiprazole for Weight Gain in Children with Autism
This trial is comparing two medicines, aripiprazole and risperidone, to see which one causes more weight gain in children with autism. The study focuses on children under 18 who have behavior problems like irritability and aggression. These medicines help by calming brain activity to improve behavior. The main goal is to find out which medicine leads to less weight gain over a few months. Aripiprazole and risperidone are both FDA-approved for treating irritability in children with autism.
Behavioural Intervention
N-Acetylcysteine for Autism
This trial aims to see if NAC, a safe nutritional supplement, can help reduce repetitive behaviors in children with autism by balancing brain chemicals. N-Acetylcysteine (NAC) has been studied for its potential benefits in treating obsessive-compulsive spectrum disorders and irritability in autism spectrum disorders.
Behavioural Intervention
AI Modules for Improving Social Communication in Autism
This trial aims to see if AI can effectively deliver interventions for individuals with autism spectrum disorder who struggle with socialization. The study will use an app on a phone or computer to provide practice and feedback on
View More Related Trials
Frequently Asked Questions
Introduction to asd
What are the top hospitals conducting asd research?
When it comes to advancing our understanding and treatment options for Autism Spectrum Disorder (ASD), several leading hospitals are at the forefront of groundbreaking clinical trials. In Boston, Massachusetts General Hospital takes the lead with eight ongoing ASD trials, demonstrating their commitment to finding new ways to support individuals with this condition. Interestingly, despite being a renowned institution in the medical field, they have yet to conduct any previous ASD trials, highlighting the evolving nature of research in this complex disorder.
Moving across the country to Houston, Red Oak Psychiatry Associates is making significant strides in ASD research as well. With six active trials focused on ASD, they are dedicated to exploring innovative approaches that can improve outcomes and quality of life for individuals affected by autism.
Meanwhile, in Philadelphia, Children's Hospital of Philadelphia has also taken up the mantle by conducting five ongoing clinical trials targeting ASD. As one of the leading pediatric healthcare providers in the nation, their dedication to researching effective interventions for children with autism highlights their unwavering commitment towards enhancing care and support services.
Further westward in Phoenix lies Southwest Autism Research and Resource Center (SARRC). This specialized center focuses exclusively on autism-related research and boasts five active clinical trials aimed at expanding our knowledge about causes and potential treatments for individuals on the spectrum. Their singular focus allows them to concentrate all efforts towards improving lives within Arizona's vibrant community.
Last but not least is Phoenix Children's Hospital also located in Phoenix where four active ASD trials are currently underway; here too researchers strive diligently toward discovering novel therapies or interventions which could potentially transform how we approach treating these autistic conditions universally.
These institutions represent beacons of hope for those impacted by ASD while embodying pioneering spirit it takes when acknowledging challenges faced by patients diagnosed under Autism Spectrum Disorders while working incessantly yearning better brighter tomorrow through extensive scientific investigation involving innovative concepts thus ensuring wider availability comprehensive solutions enabling improved quality life standards across multitude diverse communities worldwide
Which are the best cities for asd clinical trials?
When it comes to ASD clinical trials, several cities have emerged as leading centers for research and innovation. Phoenix, Arizona tops the list with 17 active trials investigating treatments like Levoleucovorin Calcium, Folinic Acid, and ML-004 (IR)/(ER) tablet. Houston, Texas follows closely behind with 15 ongoing studies focusing on interventions such as GWP42003-P and Cariprazine Flexible Dose. Boston, Massachusetts is another prominent city for ASD clinical trials with 13 active studies exploring options like Buspirone and Intranasal Oxytocin. While Orlando, Florida and Philadelphia, Pennsylvania also contribute to the field with their respective trials on various treatment modalities. These cities offer individuals living with autism spectrum disorder access to cutting-edge research that aims to improve their quality of life and unlock new possibilities in autism care.
Which are the top treatments for asd being explored in clinical trials?
When it comes to exploring potential treatments for Autism Spectrum Disorder (ASD), clinical trials have identified several promising options. Among the top contenders are:
- Daratumumab: Currently being tested in 6 active trials, with a total of 134 all-time ASD trials since its introduction in 2012.
- Belantamab mafodotin: Showing promise in 4 ongoing ASD trials and participating in a total of 26 all-time trials since its debut in 2018.
- Lenalidomide: Engaged in three current clinical trials focused on treating ASD, while also boasting an impressive track record of participation across 280 all-time studies since its inception back in 2003.
These innovative treatments hold great potential for advancing our understanding and management of Autism Spectrum Disorder, offering hope for individuals and families affected by this condition.
What are the most recent clinical trials for asd?
Exciting advancements are being made in the field of autism spectrum disorder (ASD) with recent clinical trials showcasing potential breakthrough treatments. Pimavanserin tartrate, a medication currently in Phase 2 trials, has shown promise for managing ASD symptoms. Another study focuses on the use of intranasal oxytocin, also in Phase 2, which aims to explore its effectiveness in addressing social communication difficulties associated with ASD. JZP541 and ML-004 (IR)/(ER) tablet are two other medications under investigation that have displayed encouraging results during their respective Phase 2 trials for individuals with ASD. Additionally, research into cannabidiol as a potential treatment option is underway through a Phase 1 trial. These ongoing studies offer hope for individuals living with ASD and their families as researchers strive to improve quality of life and support those affected by this complex neurodevelopmental condition.
What asd clinical trials were recently completed?
I'm sorry, but there seems to be a typo in your question. Could you please clarify what "asd" is referring to?